Cytarabine 500mg injection

Cytarabine 500mg injection

536.0 INR/Pack

Product Details:

  • Drug Type Injection
  • Physical Form Liquid
  • Recommended For Doctor
  • Dosage Guidelines As per Instructions
  • Suitable For Adults
  • Storage Instructions Cool & Dry Place
  • Click to view more
X

Cytarabine 500mg injection Price And Quantity

  • 536.0 INR/Pack
  • 40 Pack

Cytarabine 500mg injection Product Specifications

  • Doctor
  • Adults
  • Liquid
  • Cool & Dry Place
  • Injection
  • As per Instructions

Cytarabine 500mg injection Trade Information

  • Cash Advance (CA), Cash in Advance (CID), Telegraphic Transfer (T/T)
  • 5000 Pack Per Week
  • 6 Days
  • No
  • If order is confirmed we will reimburse the sample cost
  • Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa
  • All India

Product Description

1. Technical Specifications

Attribute Details
Brand Name Cytalon 500 Injection
Generic Name Cytarabine
Strength 500 mg / vial (lyophilized powder for reconstitution)
Dosage Form Injection (for Intravenous, Subcutaneous, or Intrathecal use depending on protocol)
Packaging Size Single-use vial
Packaging Type Glass vial with rubber stopper & flip-off seal
Medicine Type Anticancer Chemotherapy (Antimetabolite)
Manufacturer Neon Laboratories Ltd. (India)
Distributed By Authorized oncology distributors / hospital pharmacies

2. Product Description

Cytalon 500 Injection contains Cytarabine, a pyrimidine antimetabolite chemotherapy drug.
It inhibits DNA synthesis by incorporating into DNA and blocking DNA polymerase, leading to disruption of cell replication and death of rapidly dividing cancer cells.

It is a key part of treatment protocols for acute leukemias and certain lymphomas.


3. Product Highlights

Attribute Details
Therapeutic Category Anticancer Cytotoxic Chemotherapy (Antimetabolite)
Application Area Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Non-Hodgkin Lymphoma (NHL), CNS leukemia prophylaxis (intrathecal)
Mechanism of Action Cytidine analog converted to active triphosphate inhibits DNA polymerase & incorporates into DNA prevents DNA replication apoptosis
Administration IV infusion, SC injection, or Intrathecal injection (as per oncologists regimen)
Storage Conditions Store below 25 C; protect from light; reconstituted solution stable under refrigeration for limited time

4. Therapeutic Uses

  • Acute Myeloid Leukemia (AML): Standard drug in induction (e.g., 7+3 regimen with anthracyclines) and consolidation therapy.

  • Acute Lymphoblastic Leukemia (ALL): Used in selected regimens and CNS prophylaxis.

  • Non-Hodgkin Lymphoma (NHL): Part of salvage chemotherapy protocols.

  • Chronic Myeloid Leukemia (CML): Useful in blast crisis.

  • CNS Leukemia: Administered intrathecally as prophylaxis/treatment (preservative-free preparation required).


5. Side Effects

Common:

  • Nausea, vomiting, diarrhea

  • Stomatitis / mucositis

  • Fever, malaise

  • Rash or injection site reactions

Serious / Severe:

  • Myelosuppression: neutropenia, thrombocytopenia, anemia

  • Neurotoxicity: cerebellar dysfunction (ataxia, speech difficulty, confusion), especially at high doses

  • Hepatic toxicity: elevated liver enzymes, rare hepatic failure

  • Pulmonary toxicity: pneumonitis, ARDS (at high dose)

  • Ocular toxicity: conjunctivitis, keratitis (recommend corticosteroid eye drops in high-dose therapy)

  • Severe infections due to immunosuppression

  • Tumor lysis syndrome in patients with high leukemic burden


6. Precautions

  • Bone marrow monitoring: CBC required frequently; withhold/adjust dose if counts are very low.

  • Neurological monitoring: Especially with high-dose regimens (watch for ataxia, tremors).

  • Liver & Kidney function: Dose adjustments required in impairment.

  • Pregnancy & Breastfeeding: Contraindicated; cytarabine is teratogenic.

  • Eye protection: Use prophylactic corticosteroid eye drops with high-dose therapy.

  • Drug Interactions: May enhance toxicity with other cytotoxic agents.

  • Intrathecal use: Must be preservative-free; administer only in specialized centers.



Key Features of Cytarabine 500mg Injection

Cytarabine 500mg injection is a reliable solution designed for the treatment of hematological malignancies in adults. Its quality-assured liquid formulation is ideal for doctors to administer in clinical environments. Sourced from reputable distributors and wholesalers in India, this injection meets stringent standards for export and supply, ensuring authenticity and safety.


Safe Handling and Storage

To ensure the efficacy and safety of the Cytarabine 500mg injection, it is crucial to store the medication in a cool and dry place. This condition preserves its chemical stability and prevents degradation. Always consult the label and follow storage guidelines as provided by the manufacturer or healthcare provider.

FAQs of Cytarabine 500mg injection:


Q: How should Cytarabine 500mg injection be administered?

A: Cytarabine 500mg injection should only be administered under the guidance of a healthcare professional, typically via intravenous or subcutaneous injection, in accordance with the dosage guidelines provided by your doctor.

Q: What is the main benefit of using Cytarabine 500mg injection?

A: The primary benefit of Cytarabine 500mg injection is its effectiveness in treating specific cancers, such as leukemia, by inhibiting the growth and proliferation of malignant cells in adult patients.

Q: When should I use Cytarabine 500mg injection?

A: You should use Cytarabine 500mg injection strictly as directed by a medical professional, following the dosage and schedule set for your individual treatment plan.

Q: Where should Cytarabine 500mg injection be stored?

A: This injection must be kept in a cool and dry place to maintain its potency and ensure it remains safe for use. Avoid exposing it to direct sunlight or high temperatures.

Q: What is the correct process for handling Cytarabine 500mg injection?

A: It is essential to handle Cytarabine 500mg injection under sterile conditions in a clinical or hospital setting, ensuring hygiene and proper protocol are observed during preparation and administration.

Q: Is Cytarabine 500mg injection suitable for self-administration?

A: No, this medication is not intended for self-administration and should always be given by a healthcare provider who is experienced in cancer treatment and injection techniques.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Anticancer medicine' category



Back to top